Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > What are future profits for LABS? The research report
View:
Post by subaru1i on Sep 20, 2023 8:31am

What are future profits for LABS? The research report

indicated cannabinoid pharmaceutical API's will be worth $25 billion by 2025.   Let's say LABS only gets $10 billion of that pie so what does that do to LABS stock price when you have over $2 Billion in PROFITS?  Without having to go into the math while my mind is pondering that second cup of coffee, it is over $50 per share.  Enjoy the profit margin below and we are in VERY GOOD shape!!!  A forward looking P/E ratio in a new disruptive and fast growing segment of 25 is not unreasonable during the hyper growth phase of a company.  



MediPharm has made significant improvement in its adjusted gross margin. In the last reported quarter, Q2 2023, this was approximately 21%
Comment by Hoover69 on Sep 20, 2023 9:10am
I am long but these numbers are crazy!  Only $10 billion of the $25 billion - that is a 40% share - very unlikely.  Going from .08 to $50 - not in your lifetime.  This would result in a market cap of $20 billion making it the 35th largest company in Canada!  You lose most folks with this level of ridiculous pumping.  IMO.  GLTA.
Comment by subaru1i on Sep 20, 2023 9:20am
Then you have never invested in Broadcom or Qualcomm my good friend and experienced a new disruptive technology going through it's hyper growth phase and please note, certain words used in this post have been adopted from MBA curriculums such as disruptive technology and hyper growth phase.  You are entitled to your own opinion and so too am I.  Good luck and don't miss the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities